Affiliation:
1. Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul 04763, Republic of Korea
Abstract
Establishing universal standards for the nomenclature and classification of hydroxychloroquine retinopathy is essential. This review summarizes the classifications used for categorizing the patterns of hydroxychloroquine retinopathy and grading its severity in the literature, highlighting the limitations of these classifications based on recent findings. To overcome these limitations, I propose categorizing hydroxychloroquine retinopathy into four categories based on optical coherence tomography (OCT) findings: parafoveal (parafoveal damage only), pericentral (pericentral damage only), combined parafoveal and pericentral (both parafoveal and pericentral damage), and posterior polar (widespread damage over parafoveal, pericentral, and more peripheral areas), with or without foveal involvement. Alternatively, eyes can be categorized simply into parafoveal and pericentral retinopathy based on the most dominant area of damage, rather than the topographic distribution of overall retinal damage. Furthermore, I suggest a five-stage modified version of the current three-stage grading system of disease severity based on fundus autofluorescence (FAF) as follows: 0, no hyperautofluorescence (normal); 1, localized parafoveal or pericentral hyperautofluorescence on FAF; 2, hyperautofluorescence extending greater than 180° around the fovea; 3, combined retinal pigment epithelium (RPE) defects (hypoautofluorescence on FAF) without foveal involvement; and 4, fovea-involving hypoautofluorescence. These classification systems can better address the topographic characteristics of hydroxychloroquine retinopathy using disease patterns and assess the risk of vision-threatening retinopathy by stage, particularly with foveal involvement.
Reference55 articles.
1. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice;Levy;Arthritis Rheum.,1997
2. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision);Marmor;Ophthalmology,2016
3. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (LUMINA L);Alarcon;Ann. Rheum. Dis.,2007
4. Ocular safety of hydroxychloroquine;Bernstein;Ann. Ophthalmol.,1991
5. Bourke, B., Jones, S., Rajammal, A., Silman, A., and Smith, R. (2009). Hydroxychloroquine and Ocular Toxicity Recommendations on Screening, The Royal College of Ophthalmologists.